Featured News

A new review of strategies to support both patients and practitioners through the process of discontinuing antidepressants.

A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.

Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.

Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.

MIA's Tim Beck interviews psychologist Ian Tucker about the relationships between digital technologies, emotion, and mental health.

MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.

A new study suggests that taking antidepressants impairs empathy, while the experience of depression itself does not.

A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...

In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.

MIA’s Ayurdhi Dhar interviews Ian Parker about critical psychology, discourse and political action, and whether psychology has anything left to offer.

Lithium appears to reduce libido and sexual function, and more research into the problem is needed.

Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.

School discipline that punishes minor misbehavior may increase adolescents’ misconduct and lead to racial inequalities in school discipline.

A new review of antipsychotic trials conducted over the last 24 years finds that the placebo response rate is steadily increasing, and drug response is decreasing.

A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.

People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.

A new systematic review finds that patients report reduced symptoms but also loss of self and agency while taking antipsychotics.

A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.

Selective serotonin reuptake inhibitors (such as Prozac and Zoloft) are the most commonly prescribed medication for depression. SSRIs have long been associated with an...

The Superior Health Council of Belgium documents numerous problems with the evidence base in the manuals used to diagnose “mental illness” and cautions against their use.

New study finds that people who felt they were coerced into being hospitalized were more likely to attempt suicide later.

Psychiatrist outlines varying roles in Open Dialogue model, fostering service-user and family agency through meaningful conversations with a team of providers.

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.

Ayahuasca found to be effective in treating moderate to severe depression in low-income population.

Researchers at Johns Hopkins test paroxetine on developing brain cells and discover numerous neurotoxic effects.